A novel anti-NGF PEGylated Fab' provides analgesia with lower risk of adverse effects
ABSTRACTNerve growth factor (NGF) has emerged as a key driver of pain perception in several chronic pain conditions, including osteoarthritis (OA), and plays an important role in the generation and survival of neurons. Although anti-NGF antibodies improve pain control and physical function in patien...
Saved in:
Main Authors: | Yukari Koya (Author), Hirotsugu Tanaka (Author), Eiji Yoshimi (Author), Nobuaki Takeshita (Author), Shuji Morita (Author), Hiroki Morio (Author), Kanako Mori (Author), Hiroshi Fushiki (Author), Masazumi Kamohara (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical evaluation of topically-administered PEGylated Fab' lung toxicity
by: Danielle Freches, et al.
Published: (2019) -
NGF and therapeutic prospective: what have we learned from the NGF transgenic models?
by: Luigi Aloe, et al.
Published: (2015) -
Interpretation of Metal Fab Drawings
by: Moran, Cameren
Published: (2021) -
Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
by: Eiji Yoshimi, et al.
Published: (2010) -
Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids
by: Qing-Bin Zhang, et al.
Published: (2020)